Imaging of glutamate neurotransmitter alterations in Alzheimer's disease-Reference-Cited by-同舟云学术

Imaging of glutamate neurotransmitter alterations in Alzheimer's disease

Published:2012-10-09 Issue:4 Volume:26 Page:386-391
ISSN:0952-3480
Container-title:NMR in Biomedicine
language:en
Short-container-title:NMR Biomed.

Author:

Haris Mohammad¹,Nath Kavindra²,Cai Kejia¹,Singh Anup¹,Crescenzi Rachelle¹,Kogan Feliks¹,Verma Gaurav²,Reddy Sanjana¹,Hariharan Hari¹,Melhem Elias R.³,Reddy Ravinder¹

Affiliation:

1. Center for Magnetic Resonance and Optical Imaging, Department of Radiology; University of Pennsylvania; Philadelphia PA USA

2. Molecular Imaging, Department of Radiology; University of Pennsylvania; Philadelphia PA USA

3. Neuroradiology, Department of Radiology; University of Pennsylvania; Philadelphia PA USA

Publisher

Wiley

Subject

Spectroscopy,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/nbm.2875/fullpdf

Reference29 articles.

1. Glutamatergic systems in Alzheimer's disease;Francis;Int. J. Geriatr. Psychiatry,2003

2. Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives;Francis;J. Neurochem.,1993

3. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3T;Kantarci;Am. J. Neuroradiol.,2003

4. Reduced hippocampal glutamate in Alzheimer disease;Rupsingh;Neurobiol. Aging,2011

5. Proton MR spectroscopic study at 3 Tesla on glutamate/glutamine in Alzheimer's disease;Hattori;Neuroreport,2002

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline serum glutamate: Implications for diagnosis and prediction in mild cognitive impairment and Alzheimer’s disease of the Alzheimer’s Disease Neuroimaging Initiative;Journal of Clinical Neuroscience;2024-11

2. Multimodal investigation of neuropathology and neurometabolites in mild cognitive impairment and late-life depression with 11C-PiB beta-amyloid PET and 7T magnetic resonance spectroscopy;Neurobiology of Aging;2024-10

3. Rescue of synaptosomal glutamate release defects in tau transgenic mice by the tau aggregation inhibitor hydromethylthionine;Cellular Signalling;2024-09

4. Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer’s disease;Gut Microbes;2024-07-15

5. Estimating the synaptic density deficit in Alzheimer’s disease using multi-contrast CEST imaging;PLOS ONE;2024-03-14